Characteristics

All

Gal-1

p-value

Gal-1 tumor cells

p-value

(N = 70)

Weak

(N = 22)

Strong

(N = 48)

Weak

(N = 24)

Strong

(N = 46)

No.

%

No.

%

No.

%

No.

%

No.

%

Age (years)

Mean ± SD

50.24 ± 9.58

49.13 ± 9.13

50.75 ± 9.84

0.265Ÿ

50.50 ± 9.82

50.10 ± 9.56

0.848Ÿ

Median

(Range)

52.50

(27 - 62)

50

(27 - 61)

54

(27 - 62)

53.50

(27 - 61)

52

(27 - 62)

Grade

Low

18

27.7%

13

72.2%

5

27.8%

<0.001‡

16

88.9%

2

11.1%

<0.001‡

High

52

74.3%

9

17.3%

43

82.7%

8

15.4%

44

84.6%

LN

Negative

22

31.4%

10

45.5%

12

54.5%

0.087‡

11

50%

11

50%

0.061‡

Positive

48

68.6%

12

25%

36

75%

13

27.1%

35

72.9%

Stage

Stage I

8

11.4%

6

75%

2

25%

0.003§

5

62.5%

3

37.5%

0.010§

Stage II

12

17.1%

4

33.3%

8

66.7%

6

50%

6

50%

Stage III

32

45.7%

10

31.2%

22

68.8%

10

31.2%

22

68.8%

Stage IV

18

25.7%

2

11.1%

16

88.9%

3

16.7%

15

83.3%

CA125 (u/ml)

Mean ± SD

1071.31 ± 666.91

806.77 ± 641.61

1192.56 ± 649.05

0.025Ÿ

762.16 ± 643.79

132.60 ± 626.57

0.010Ÿ

Median

(Range)

1238.50

(69 - 2008)

1226.50

(69 - 1965)

1246

(76 - 2008)

865

(69 - 2008)

1248.50

(76 - 2005)

Gal-1 (ng/ml)

Mean ± SD

334.84 ± 187.67

210.04 ± 135.00

392.04 ± 181.47

<0.001Ÿ

253.41 ± 171.94

377.32 ± 183.07

0.002Ÿ

Median

(Range)

277

(32 - 763)

173.50

(35 - 598)

282

(32 - 763)

263

(35 - 651)

282

(32 - 763)

Gal-1

Weak

22

31.4%

15

68.2%

7

31.8%

<0.001‡

Strong

48

68.6%

7

18.8%

39

81.2%

Gal-1 tumor cells

Weak

24

34.3%

15

62.5%

9

37.5%

<0.001‡

Strong

46

65.7%

7

15.2%

39

84.8%